Matthew E. Korenberg

Matthew E. Korenberg

Chief Financial OfficeratPalvella Therapeutics· In proxies 2024–2025

Pay in FY2025Palvella Therapeutics stock +772.3% the same year

Matthew E. Korenberg was paid $2.0M in FY2025 (Dec). Palvella Therapeutics stock rose 772.3% that year.

Pay$100 in the stock at the end of FY23 → $719
Pay is from the Summary Compensation Table of each Palvella Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Palvella TherapeuticsPublic company · 2 yr
    • Chief Financial Officer2024 – Present · 2 yrStock in role +937%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?